| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant therapy for EGFR mutant and ALK positive NSCLC: Current data and future prospects
|
Chuang, Jody C.
|
|
2015
|
90 |
1 |
p. 1-7
7 p.
|
artikel
|
| 2 |
Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients
|
Kudo, Yujin
|
|
2015
|
90 |
1 |
p. 47-54
8 p.
|
artikel
|
| 3 |
Authors’ response—Risk of malignancy in pulmonary nodules: a validation study of four prediction models
|
Al-Ameri, Ali
|
|
2015
|
90 |
1 |
p. 119-120
2 p.
|
artikel
|
| 4 |
BCL2-like 11 intron 2 deletion polymorphism is not associated with non-small cell lung cancer risk and prognosis
|
Cho, Eun Na
|
|
2015
|
90 |
1 |
p. 106-110
5 p.
|
artikel
|
| 5 |
Bidirectional signaling between TM4SF5 and IGF1R promotes resistance to EGFR kinase inhibitors
|
Choi, Jungeun
|
|
2015
|
90 |
1 |
p. 22-31
10 p.
|
artikel
|
| 6 |
Breath carbonyl compounds as biomarkers of lung cancer
|
Li, Mingxiao
|
|
2015
|
90 |
1 |
p. 92-97
6 p.
|
artikel
|
| 7 |
Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT
|
Francis, Roslyn J.
|
|
2015
|
90 |
1 |
p. 55-60
6 p.
|
artikel
|
| 8 |
Contents
|
|
|
2015
|
90 |
1 |
p. v-vi
nvt p.
|
artikel
|
| 9 |
Cost-effectiveness analysis of EGFR mutation testing and gefitinib as first-line therapy for non-small cell lung cancer
|
Narita, Yusuke
|
|
2015
|
90 |
1 |
p. 71-77
7 p.
|
artikel
|
| 10 |
Critique of Al-Ameri et al. (2015) – Risk of malignancy in pulmonary nodules: A validation study of four prediction models
|
Perandini, Simone
|
|
2015
|
90 |
1 |
p. 118-119
2 p.
|
artikel
|
| 11 |
Definitive chemotherapy and radiotherapy in patients with stage II non-small cell lung cancer: A population-based outcomes study
|
Sampath, Sagus
|
|
2015
|
90 |
1 |
p. 61-64
4 p.
|
artikel
|
| 12 |
Distance from accessible specialist care and other determinants of advanced or unknown stage at diagnosis of people with non-small cell lung cancer: A data linkage study
|
Tracey, Elizabeth
|
|
2015
|
90 |
1 |
p. 15-21
7 p.
|
artikel
|
| 13 |
Editorial Board
|
|
|
2015
|
90 |
1 |
p. iii-
1 p.
|
artikel
|
| 14 |
Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls
|
Xia, Shu
|
|
2015
|
90 |
1 |
p. 78-84
7 p.
|
artikel
|
| 15 |
Increased expression of transcription factor EB (TFEB) is associated with autophagy, migratory phenotype and poor prognosis in non-small cell lung cancer
|
Giatromanolaki, Alexandra
|
|
2015
|
90 |
1 |
p. 98-105
8 p.
|
artikel
|
| 16 |
Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer
|
Sjøblom, Bjørg
|
|
2015
|
90 |
1 |
p. 85-91
7 p.
|
artikel
|
| 17 |
Lymph node metastasis in clinical stage IA peripheral lung cancer
|
Wang, Lin
|
|
2015
|
90 |
1 |
p. 41-46
6 p.
|
artikel
|
| 18 |
Phase II study of a combination regimen of gefitinib and pemetrexed as first-line treatment in patients with advanced non-small cell lung cancer harboring a sensitive EGFR mutation
|
Yoshimura, Naruo
|
|
2015
|
90 |
1 |
p. 65-70
6 p.
|
artikel
|
| 19 |
Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma
|
Yamagishi, Tomoko
|
|
2015
|
90 |
1 |
p. 111-117
7 p.
|
artikel
|
| 20 |
RNF111/Arkadia is regulated by DNA methylation and affects TGF-β/Smad signaling associated invasion in NSCLC cells
|
Chen, Hongbing
|
|
2015
|
90 |
1 |
p. 32-40
9 p.
|
artikel
|
| 21 |
Temporal trends in the incidence and relative survival of non-small cell lung cancer in Canada: A population-based study
|
Akhtar-Danesh, Noori
|
|
2015
|
90 |
1 |
p. 8-14
7 p.
|
artikel
|
Tijdschrift beschrijving